Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets Authority

    NEXT STORY
    Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board
    PREV STORY
    Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE

    Strong financial performance in H1 2018 Three medium-term strategic growth drivers fully on track ...

    author_avatar
    NASDAQ Market News

    Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference

    SAN DIEGO, March 16, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    New Health Economics Studies Highlight the Potential for Paratek Pharmaceuticals’ Omadacycline to Provide Cost-Savings Compared to Standard of Care for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections

    VIENNA, Austria, April 24, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today ...

    author_avatar
    NASDAQ Market News